Cellebrite DI (CLBT) Cost of Revenue (2020 - 2025)
Cellebrite DI's Cost of Revenue history spans 6 years, with the latest figure at $38.6 million for Q4 2025.
- Quarterly Cost of Revenue rose 8.55% to $38.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $154.8 million through Dec 2025, up 16.94% year-over-year, with the annual reading at $154.8 million for FY2025, 147.33% up from the prior year.
- Cost of Revenue came in at $38.6 million for Q4 2025, down from $38.8 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $38.8 million in Q3 2025 to a low of $16.5 million in Q1 2021.
- The 5-year median for Cost of Revenue is $27.2 million (2023), against an average of $28.6 million.
- Year-over-year, Cost of Revenue skyrocketed 40.81% in 2022 and then increased 5.11% in 2023.
- Cellebrite DI's Cost of Revenue stood at $21.2 million in 2021, then grew by 11.44% to $23.7 million in 2022, then rose by 25.03% to $29.6 million in 2023, then grew by 20.04% to $35.5 million in 2024, then increased by 8.55% to $38.6 million in 2025.
- Per Business Quant, the three most recent readings for CLBT's Cost of Revenue are $38.6 million (Q4 2025), $38.8 million (Q3 2025), and $38.7 million (Q2 2025).